Skip to main content
logo
Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0900
+0.010012 (12.52%)
At close: Oct 15, 2026

Altamira Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Market Capitalization
10162730
Market Cap Growth
12.50%-72.84%-75.59%-78.93%-10.02%459.12%
Enterprise Value
115111830
Last Close Price
0.090.113.4897.00726.001048.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
PB Ratio
0.130.060.18-0.631.881.58
P/TBV Ratio
-0.190.45--3.46

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Debt / Equity Ratio
0.190.060.02-0.760.040.03
Net Debt / Equity Ratio
0.19-0.10-0.08-0.76-0.03-0.64
Net Debt / EBITDA Ratio
----1.160.082.04
Net Debt / FCF Ratio
-0.180.100.05-0.750.032.22
Quick Ratio
0.091.160.780.060.343.74
Current Ratio
0.111.321.380.140.843.83
Return on Equity (ROE)
-108.79%-118.79%--764.37%-44.88%-71.91%
Return on Assets (ROA)
-45.75%-48.12%-51.58%-26.97%-16.70%-21.99%
Return on Capital Employed (ROCE)
-115.40%-91.50%-81.40%83.60%-37.30%-29.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Earnings Yield
-1098.95%-2250.19%-311.15%-489.87%-69.52%-30.99%
FCF Yield
-854.80%-1653.94%-925.68%-160.34%-55.73%-18.30%
Buyback Yield / Dilution
-351.86%-476.54%-978.83%-37.51%-120.26%-